Literature DB >> 34219732

Model-Based Projection of Dementia Prevalence in China and Worldwide: 2020-2050.

Fangyu Li1,2,3,4,5, Wei Qin1,2,3,4,5, Min Zhu1,2,3,4,5, Jianping Jia1,2,3,4,5.   

Abstract

BACKGROUND: Current and future incidence and prevalence estimates of dementia are essential for public health planning.
OBJECTIVE: The objective was to establish prediction model of incidence and estimate the prevalence of dementia in the Chinese and worldwide population from 2020 to 2050.
METHODS: A model-based method was used to project the dementia prevalence from 2020 to 2050 in China, which required incidence, the mortality rate for individual without dementia, and the relative risk of death. Furthermore, we detected the impact of intervention on the prevalence projection for dementia using a simulation method. We applied the same method to other projections worldwide.
RESULTS: In 2020, the model predicted 16.25 million (95%confidence interval 11.55-21.18) persons with dementia in China. By 2050, this number would increase by approximately three-fold to 48.98 million (38.02-61.73). Through data simulation, if the incidence of dementia decreased by 10%every 10 years from 2020 after intervention and prevention, the number of dementia cases by 2050 was reduced by 11.96 million. This would reduce the economic burden by US $639.04 billion. In addition, using this model, dementia cases grew relatively slowly over the next few decades in the United States of America, the United Kingdom, and Japan, with percentage changes of 100.88%, 65.93%, and 16.20%, respectively.
CONCLUSION: The number of people with dementia in China is large and will continue to increase rapidly. Effective interventions could reduce the number of patients drastically. Therefore, prevention and control strategies must be formulated urgently to reduce the occurrence of dementia.

Entities:  

Keywords:  China; dementia; model-based; prevalence; projection

Year:  2021        PMID: 34219732     DOI: 10.3233/JAD-210493

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  4 in total

1.  Rhinacanthin-C but Not -D Extracted from Rhinacanthus nasutus (L.) Kurz Offers Neuroprotection via ERK, CHOP, and LC3B Pathways.

Authors:  Varaporn Rakkhittawattana; Pharkphoom Panichayupakaranant; Mani I Prasanth; James M Brimson; Tewin Tencomnao
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-20

2.  Novel Design of Neuropeptide-Based Drugs with β-Sheet Breaking Potential in Amyloid-Beta Cascade: Molecular and Structural Deciphers.

Authors:  Cosmin Stefan Mocanu; Marius Niculaua; Gheorghita Zbancioc; Violeta Mangalagiu; Gabi Drochioiu
Journal:  Int J Mol Sci       Date:  2022-03-05       Impact factor: 5.923

3.  Is there a common latent cognitive construct for dementia estimation across two Chinese cohorts?

Authors:  Yuyang Liu; Yanjuan Wu; Jingheng Cai; Yun Huang; Yuntao Chen; Tishya M Venkatraman; Sophia Lobanov-Rostovsky; Piotr Bandosz; Yung-Jen Yang; Yu-Tzu Wu; Jing Liao; Yuantao Hao; Eric J Brunner
Journal:  Alzheimers Dement (Amst)       Date:  2022-09-14

4.  Prevalence and correlates of suspected dementia in older adults receiving primary healthcare in Wuhan, China: A multicenter cross-sectional survey.

Authors:  Zong-Qin Wang; Lei Fei; Yan-Min Xu; Fang Deng; Bao-Liang Zhong
Journal:  Front Public Health       Date:  2022-10-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.